Publications
108 publications
Funding
5 grantsView NIH portfolio on RePORTER ↗
Active
3 grants- MPIP50CA092629-25Project 2: Overcoming Microenvironment-Mediated Resistance to AR Pathway Inhibition in High-Risk Prostate CancerNCI · 2001–2027 · via NIH RePORTER
- MPIR01CA257811-05PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapyNCI · 2021–2027 · via NIH RePORTER
Completed grants (2)
- MPIU54CA224079-04Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancerNCI · 2017–2023 · via NIH RePORTER
- PIR01CA182503-05Defining Response and Resistance to PI3K and AR inhibition in Prostate CancerNCI · 2014–2020 · via NIH RePORTER